A randomized phase III trial of the Southern Italy Oncology Group (G.O.I.M.). of mitomycin C plus vindesine and cisplatin (MVP regimen) versus vinorelbine plus cisplatin (PV regimen) in stage III–IV non small cell lung cancer
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol 83
◽
pp. 302-312
◽
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7066-7066
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):